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Available online 19 September 2012With the aging of the population, the interest in clinical trials concerning frail elderly
patients has increased. Evidence-based practice for the elderly patient is difficult because
elderly patients, especially the frail, are often excluded from clinical trials. To facilitate the
participation of frail elderly patients in clinical trials, investigators should be more aware of
possible barriers when setting up research. While conducting a trial entitled ‘A randomized
controlled trial of geriatric liaison intervention in frail surgical oncology patients’ (LIFE) the
main problem was low inclusion rates. This was due to: 1) limited physical and cognitive
reserve of frail elderly patients making participation and extra visits to the hospital a
burden for patients; 2) difficulty with understanding written information and information
given by telephone; and 3) insufficient awareness of the study by health care professionals.
To increase inclusion rates, follow-up measurements were taken at a home visit. To
overcome barriers to understanding written information and information given over the
phone, patients were informed face to face and questionnaires were filled in an interview
format. To increase awareness, posters, pencil and sweets with the logo of the study were
distributed and the study protocol was repeatedly explained to new staff. Moreover, it was
checked if possible eligible patients coming to the hospital were indeed screened for
participation. The mentioned measures, increased inclusion rates but also caused an
increased time investment and consequently extra financial resources for staff costs.





The world's population is aging, with the prediction being that
in 2050, when the graying of the population reaches a peak,
27.6% of Europe's population will be over 65 years of age [1]. In
the past, elderly patients were often withheld treatmentiatric medicine. The top
ion in frail surgical oncol
for the Elderly, Universit
03618888.
. Hempenius).
r Ltd. All rights reserved.because of their age. Today, with an increasing elderly popu-
lation and growing treatment options, physicians are re-
sponsible for choosing the optimal treatment for the elderly
patient. However, evidence-based practice is difficult because
elderly patients, especially the frail, are often excluded from
clinical trials [2–4]. The perceived extra burden to frail patientsic of her PhD dissertation concerns the LIFE study: ‘A randomized
ogy patients’.
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whether the elderly patient might benefit from the trial
hamper their inclusion [3,5–8]. To facilitate the participation
of frail elderly patients in clinical trials, investigators should be
more aware of possible barrierswhen setting up research. This
paper offers an overview of the problems encountered when
conducting a randomized controlled trial in a frail elderly
population and possible solutions.2. The Trial
This article is based on practical experience gained while
conducting a trial entitled ‘A randomized controlled trial of
geriatric liaison intervention in frail surgical oncology pa-
tients’ (LIFE). The objective of LIFE was to show that a geriatric
liaison intervention in frail elderly patients undergoing a
surgical procedure for a solid tumor would decrease the
occurrence of delirium and consequent morbidity and mor-
tality, without an increase in costs. Three centers participated
in this study: center A, a university medical center; center B, a
large teaching hospital; and center C, an inner-city hospital.
Patients over 65 years of age undergoing surgery for a solid
tumor were assessed with the Groningen Frailty Indicator
(GFI) [9] at the outpatient departments of general surgery. The
GFI is a short 15-item screening instrument used to determine
an individual's level of frailty. It screens for the loss of functions
and resources in four domains of functioning: physical (mobility
functions, multiple health problems, physical fatigue, vision,
andhearing), cognitive (cognitive functioning), social (emotional
isolation), and psychological (depressed mood and feelings
of anxiety). Patients with a GFI score greater than 3 are regarded
as frail [9,10] and were recruited for this study. Patients with
any psychological, familial, sociological or geographical cir-
cumstances potentially hampering compliance with the study
protocol and follow-up schedule were excluded from partici-
pation. Patients unable to fill in the questionnaires were also
excluded. From June 2007 to December 2009, 238 patients were
included and randomized.
The intervention consisted of a preoperative consultation
with a geriatrician and an individual treatment plan targeted
at several risk factors for delirium, daily visits by a geriatric
nurse during the hospital stay and advice on managing any
problem encountered on the basis of a nine-item checklist.
The primary outcome was the occurrence of delirium up to
10 days postoperatively. In both groups the Delirium Obser-
vation Scale (DOS) [11] was used to screen for delirium. In the
case of a mean DOS score≥3 (possible delirium) a geriatrician
or psychiatrist examined the patient to confirm the diagnosis
according to the Diagnostic and Statistical Manual of Mental
Disorders, Fourth Edition (DSM IV) criteria.
Data were collected at admission, during the hospital stay
and three months after discharge. Patients were asked to com-
plete several questionnaires which was estimated to take
30 min at admission (collection of demographic data, assess-
ment of the quality of life, measured by a Short Form-36 (SF-36)
score [12] and care dependency, measured by the Care
Dependency Scale (CDS) [13]), 15 min daily during the hospital
stay (a nine-item checklist concerning orientation, mobility,
anxiety, senses, pain, sleep, intake, defecation and infectioncompleted by a research nurse), 15 min at discharge (SF-36 and
CDS), and 15–30 min for 3 months postoperatively (SF-36, living
situation).
Funding was obtained from the Netherlands Organisation
for Health Research and Development, trial number
945-07-516. The study was approved by the Medical Ethical
Committee of the University Medical Center Groningen
(UMCG).3. The Main Problem: Inclusion
In the surgical ward of university center A, a minimum of 180
patients aged 65 years and over are treated for a solid tumor
each year. In a prospective study, 85 consecutive admissions
for oncological surgery in UMCG were assessed with the GFI
and 30% of these patients had a score greater than 3. Based on
this pilot study, it was expected that one-third of these pa-
tients would be frail. With an expected inclusion rate of 90%, it
was calculated that around four patients from center A could
be included per month. After similar calculations this number
amounted to four patients per month from center B and two
from center C. Financial support was available for a total of
30 months: from April 2007 to October 2009. During the course
of the study it became clear that the actual inclusion rate fell
short of expectations (see Figs. 1 and 2).4. Reasons for Low Inclusion Rate and
Possible Solutions
4.1. High incidence of refusal to participate
From June 2007 to December 2009, 1256 patientswere screened
and 359 (28.6%) were found to be frail. Thirty-eight patients
failed to meet the inclusion criteria (10.6%). Of the remaining
321 eligible patients, 238 (74.1%) were randomized. This was
much less than the expected inclusion rate of 90%. The most
important reasons for not entering the study were the refusal
to participate (n=54; 16.8%) and logistics (planning and trans-
portation) (n=12; 3.7%) (Fig. 3).
It appeared that patients refused to participate primarily
because they felt overburdened by their physical condition,
stress, and concerns about the future after the cancer diagnosis.
Additional visits and travel to the hospital also discouraged
them from participation. This latter problem was solved by
home visits and flexible scheduling; for example, appointments
related to the study were combined with a scheduled appoint-
ment at the hospital to prevent unnecessary travel. In addition,
many elderly reported that they did not want to be a burden to
their relatives by asking to be accompanied. In general, family
members had a major influence on the decision to participate.
The approval or rejection of relatives largely determined the
decision of a frail older patient to participate in the trial. For this
reason, relativeswere involved in the informed consent process
which took place when the research nurse visited eligible
patients and their accompanying relatives at the outpatient
clinics. The research nursewas able to give them information in
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In center A the inclusion rateswere lower than expected because
of problems in the initial communication process. A research
nurse was appointed who had vast research experience, but no
specific experience in the care for and communication with the
elderly patient. Potential eligible patients were informed about
the study by nurses on the outpatient clinics. Often only written
information was given. Afterwards patients were contacted by
telephoneby the researchnurse for participation.Whenapatient
decided to participate, informed consent had to be returned by
post, which was an additional barrier.
In this population it is important to take extra time when
communicating, as communicative capacity is often restricted
because of a higher incidence of sensory loss (hearing and
visual problems), speech problems such as aphasia and dys-
arthria and cognitive decline. In our experience it is by far
more preferable to communicate with patients face to face as
they seem to understand information given in this way much
better than by telephone. Jansen (2009) studied communica-
tion between the older patient with cancer and clinician [14]
and found that patients are better able to recall information
when: 1) only the most important information is discussed
with the elderly patient and the duration of a consultation is
limited; 2) a companion is present during the consultation— a
patient who prefers to be accompanied should be stimulated
to bring someone with them; 3) empathy is expressed when a
patient shows emotion. These recommendations should be
taken into account when communicating with older adults.
After persistent disappointing inclusion rates, it was
decided that a nurse with ample experience in caring for and
communicating with elderly patients should be appointed.
Her efforts increased the inclusion rate substantially from
December 2008 (see Fig. 2). She was informed when there was
an eligible patient on the outpatient clinic and then visited the
patient immediately at the outpatient clinic visit to give them
face to face information. Then questions of the patient and
relatives could be answered and informed consent could be
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Fig. 1 – Expected versus actual inclusion in the LIFE study.
Trend lines and formula added for the actual inclusion rates
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Fig. 2 – Inclusion per center. Trend lines added for the actual
inclusion rates for the first and second parts of the study.4.3. Relocation of frail patients
Unexpectedly, frail patients were often operated on in the uni-
versity hospital near center C. Because the participation of center
C was not cost-effective, funding was partly withdrawn and the




n = 1256 
GFI* > 3 
n = 359 
GFI* ≤ 3 
n = 897 
Stop 
Informed consent and 
randomization 
n = 238 
Not included (n = 121): 
-failure to meet inclusion criteria 
(n = 38) 
-refusal to participate (n = 54) 
-logistics (n = 12) 
-unknown (n = 17) 
Fig. 3 – Flow chart of inclusion rates. *GFI = Groningen Frailty Indicator, a screening instrument used to determine an
individual's level of frailty. Patients with a score greater than 3 were regarded as frail and were recruited for this study.
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In all centers it became apparent that 10–20% of eligible patients
were not screened. To increase general awareness of the study,
posters, pencils and sweet jars with the logo of the study were
distributed to the outpatient clinics and wards. During the
followingmonths every patient that visited the outpatient clinic
and was possibly eligible for LIFE was marked in the patient list
by the research nurses. Afterwards it was checked if these
patientswere indeed screened. Also, weekly reports of screening
results were presented to the nursing staff involved. In addition,
because all surgical patients were discussed inmultidisciplinary
meetings before treatment, patient lists of these meetings were
checked weekly to detect unscreened patients.
In center B, the study started months later than planned.
While the start of the study was agreed to by all medical staff,
the nurses were poorly informed. The success of this study
depended largely on the commitment of nurses in the outpa-
tient clinics and the wards.
Again it became clear that supplying adequate information
and instructions to the health care professionals involved
benefited the progress of the study. For both doctors and
nurses, clinical research oftenmeans that there are additional
tasks to do alongside their daily care activities. Our experience
indicates that the research tasks usually are low in priority,
especially when the provision of information is poor. It
is preferable to plan time for research tasks in the usual
schedule. It is also desirable to repeatedly explain the study
protocol and continue to remind existing staff and instruct
new staff in this regard. We realize that this problem is not
specific to research in a frail elderly population, but is impor-
tant for clinical research in general.
An additional measure taken to increase the inclusion rate
was the involvement of the departments of gynecology; ear,
nose and throatmedicine; andmaxillofacial surgery in centersA and B. This required further investment of time and re-
sources to inform and educate the staff.
Due to the above-mentioned measures, the inclusion rates
increased in centers A and B. The trend in the inclusion rate for
the second part of the study shows an increased slope in
comparison with the first part (Fig. 2). In center C the inclusion
rate decreased during the second part of the study (Fig. 2).
One reason was that the geriatrician responsible for the
study moved to another hospital. Additionally, the distance
between center C and centerA (thework location of the primary
investigator)made intensive supervision difficult. These factors
may have influenced the low inclusion rate in center C.
After 30 months the estimated number of patients had not
yet been recruited, resulting in a prolonged inclusion phase of
8 months and the redistribution of financial resources. Due to
the disappointing results in center C, the inclusion phase and
financial support were not prolonged there.5. Other Problems and Solutions
Although the inclusion of frail elderly patients in this trial
proved to be the biggest problem, we encountered several other
issues influencing the success of this study.
5.1. Sample size calculation: estimating incidences was
difficult due to the heterogeneity of the population
To achieve a power of 80%with an α of 5% (one-sided), a β of 95%
and an expected drop-out rate of 10%, a total inclusion of 294
patients was calculated for this study. The reported incidence of
delirium varies widely between and within the populations
under investigation. Incidences vary from less than 10% up to
50% after orthopedic [15], abdominal [15,16] and cardiac surgery
[17]. Based on these data the incidence of delirium in our
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risk population, we thought that an incidence of 30% was a
conservative estimate.We expected to find an absolute reduction
of 15%. Based on the results of Inouye (1999), we felt that aiming
for a total reduction of 15% (and thus a final incidence of 15%)
would be feasible [18]. Inouye et al. found a final incidence of 10%.
The preliminary results of the LIFE study showed an un-
expectedly lower overall incidence of delirium than expected. A
great variance in outcome measures is inherent to the elderly
population due to heterogeneity with respect to physical, men-
tal and social functioning. We recommend using cautious
estimates of incidence when calculating sample size in this
population to maintain power.
5.2. Time management
All parts of the trial (recruitment, intervention, measurements
and analysis) took more time than anticipated and, conse-
quently, more financial resources than calculated. We had
calculated an overall mean time investment of 2 h per patient
but the actual time investment per patient amounted to be
more than 6 h. Since patients in this population have difficulty
interpreting self-administered questionnaires, the questions
were administered in an interview form. Studies have shown
that frail older adults have difficulty with self-administered
questionnaires. For example, the Short Form-36 (SF-36) [12]
has proven to be reliable and valid in a frail elderly population
only when used in an interview setting [19,20].
The interview setting used made it difficult to strictly
adhere to the content of the questionnaires due to the addition
of personal comments and questions leading the patients
to disclose tangential information. This contributed to the
questionnaires takingmore time than anticipated. In addition,
in the course of the study some questionnaires were added
to the protocol, namely the Mini-Mental State Examination
(MMSE) [21] tomeasure preoperative cognitive functioning and
3 months after, the Geriatric Depression Scale (GDS) [13] to
measure preoperative depression, and the Mini Nutritional
Assessment — Short Form (MNA-SF) [22] to measure preoper-
ative malnutrition.
The additional visit to the hospital for the follow-up mea-
surement at three months was a stressful experience for many
patients. It was necessary to adapt the research protocol to allow
visits to the home for thismeasurement, taking into account the
patients' physical and cognitive abilities. The travel time needed
increased the time investment per patient considerably.6. Other Potential Pitfalls
Beyond the problems we encountered while conducting the
LIFE study there are other potential pitfalls. We want to em-
phasize the importance of the selection of patients. Patients
who are too frail or too fit should be excluded to optimize
internal validity (the need to focus the study group to max-
imize the chances of detecting an impact of the intervention if
it exists). However, eligibility criteria should not be too strict
with respect to external validity (the ability to generalize to a
larger population) [5]. For example, in the LIFE study, patientsunable to understand questionnaires were excluded, although
patients with decreased cognitive abilities are at high risk to
develop delirium. Furthermore patients undergoing surgery
for a superficial tumor (skin, breast) were included in the
study, although they are at low risk to develop postoperative
delirium. Both criteria may have lowered the delirium inci-
dence rate in our study and reduced the change to show
effectiveness of the intervention.
Moreover, problemswith judging decision-making capacity
due to cognitive impairment may be a barrier to the inclusion
of frail older adults in clinical trials. The gold standard for
making a judgment about capacity is an evaluation of the
criteria for decision-making capacity in a semi-structured
interview [16]. We did not use this in our study, but it seems to
be a useful tool for inclusion of elderly patients with cognitive
impairment in clinical trials.7. Conclusion
Executing a clinical trial in frail elderly patients requires an
adjusted approach.When designing a protocol and scheduling
measurements, physical (mobility problems, sensory losses
and reduced exercise capacity) and mental abilities (cognitive
impairments) of frail elderly patients should be evaluated and
taken into account.Members of the research teamshould have
an affinity with the elderly population and be aware of the fact
that extra time and financial resources are needed when
conducting research in a frail elderly population.Disclosures and Conflict of Interest Statements
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